Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
Citation
Dawson , J , Robertson , M , Dickie , D A , Bath , P , Forbes , K , Quinn , T , Broomfield , N M , Dani , K , Doney , A , Houston , G , Lees , K R , Muir , K W , Struthers , A , Walters , M , Barber , M , Bhalla , A , Cameron , A , Dyker , A , Guyler , P , Hassan , A , Kearney , M T , Keegan , B , Lakshmanan , S , Macleod , M J , Randall , M , Shaw , L , Subramanian , G , Werring , D & McConnachie , A 2023 , ' Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial ' , EClinicalMedicine , vol. 57 , 101863 . https://doi.org/10.1016/j.eclinm.2023.101863
Rights
Copyright © 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).